Clinical Study

Comparative Study of the Effects of 1% Atropine on the Anterior Segment

Table 2

Univariate analysis of the associations between ΔTIA and the ocular and general parameters.

VariablesUnivariate analysis
Regression coefficient (95% confidence interval)R2 value

Age−0.324 (−1.049 to 0.463)−0.0080.578
Sex−3.256 (−15.717 to 0.085)0.0170.164
ΔAOD500 (mm)26.64 (14.871 to 38.146)0.251<0.05
ΔACD (mm)3.007 (−13.465 to 19.478)−0.0150.716
ΔLV (mm)8.448 (−2.589 to 19.741)0.0090.226
ΔACW (mm)0.766 (−2.881 to 3.766)−0.0140.665
ΔIT750 (mm)1.743 (−17.353 to 21.07)−0.0170.871
ΔIT1500 (mm)−9.287 (−35.575 to 18.34)−0.0080.467
ΔIA (mm67)−2.34 (−8.122 to 5.676)−0.0120.557
ΔCBT0 (mm)5.693 (−7.496 to 18.84)−0.0070.436
ΔCMTmax (mm)8.252 (−19.678 to 37.582)0.0120.574
ΔTCA (CA)0.189 (0.057 to 0.344)0.1230.004
ΔTCPD (mm)−4.274 (−14.436 to 6.66)−0.0090.484
ΔICPD (mm)−3.513 (−17.697 to 12.185)−0.0140.641
ΔSIA (IA)0.4 (0.204 to 0.591)0.185<0.05
ΔSCPA (CP)0.071 (−0.264 to 0.331)−0.0120.579
AOD500 (mm)−2.007 (−13.807 to 11.251)−0.0160.735
ACD (mm)−6.162 (−16.044 to 3.72)0.010.217
LV (mm)5.148 (−8.016 to 18.312)−0.0070.437
ACW (mm)1.018 (−2.317 to 4.353)−0.0110.543
IT750 (mm)10.254 (−13.994 to 33.17)−0.0030.371
IT1500 (mm)−0.945 (−36.492 to 35.326)−0.0180.954
IA (mm54)−0.745 (−9.2 to 7.709)−0.0170.86
CBT0 (mm)8.709 (−13.341 to 32.765)−0.0050.399
CMTmax (mm)3.865 (−23.512 to 30.92)−0.0160.785
TCA (CA)0.114 (−0.046 to 0.268)0.0130.193
TCPD (mm)−11.043 (−24.1 to 2.248)0.0220.137
ICPD (mm)−6.593 (−21.547 to 8.072)−0.0080.469
SIA (IA)−0.016 (−0.344 to 0.312)−0.0180.922
SCPA (CP)−0.007 (−0.299 to 0.286)−0.0180.964
TIA (IA)0.375 (0.128 to 0.631)0.960.01